This chemical is primarily utilized in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of drugs targeting neurological disorders, including those used in the treatment of Parkinson's disease and other neurodegenerative conditions. Its structure allows for the introduction of functional groups that enhance the biological activity of the final drug molecule. Additionally, it is employed in research settings for the development of novel therapeutic agents, leveraging its reactivity and versatility in organic synthesis. Its application extends to the creation of ligands for receptor binding studies, aiding in the understanding of molecular interactions in biological systems.